 In Q4/2017, the Company and its subsidiary recorded total sales of Baht 1,531 million, an increase of 2% YoY, following growth from domestic CMG launching new products as well as continue growth from

net profit decreased by 47.88% or equal to Baht 15.60 million as compared to Baht 29.93 million which was recorded in the same quarter of 2016. For 1H17, the Company recorded the net profit of Baht

comprehensive income (expense) for the period (87.66 ) (259.81 ) 172.15 66.26% (49.90%) (87.81%) Basic earnings per share-Owners of the Company (0.10 ) (0.30 ) 0.20 65.96% (0.06%) (0.10%) Attributable to Owners

set up full allowance for impairment for Thanh Cong investment prior to the sale, and reversed such expense in the profit and loss in the same period.  The Company recognized share of profit from

, the Company and its subsidiary recorded total sales of Baht 1,361 million, a decrease of 10% YoY, following a drop in export CMG and export branded. However, domestic CMG grew outstandingly from new

its subsidiaries (the “Company”) has recently submitted the reviewed interim financial statements for the period ended 30 September 2017 to the Stock Exchange of Thailand with a view to share the

dropped from previous quarter resulting to stock loss during 2Q2020. As a result, the Company had a Stock Loss & NRV of THB 374 million, recorded EBITDA of THB -120 million, down 236% compared to 2Q2019

or increased by Baht 27.53 million or 65.66% from the year 2018. The Company’s subsidiaries financial cost recorded in asset for construction in year 2018. (10) Share of profit (loss) from investment

first nine-months of 2022, the total consolidated revenues were 16,780 million baht, increasing of 1,183 million baht or 8% y-y. In the third quarter of 2022, the Company recorded revenue at 5,820 million

6,800 tons in this quarter, therefore, the company recorded methyl ester sales volume at 111,590 tons, an increase of 21,490 tons or 24% compared to the same quarter of the previous year. Meanwhile fatty